This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties ...

As the J.P. Morgan Healthcare Conference started in San Francisco on Monday, AbbVie linked up with Simcere with a $1 billion ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...

U.S. industry conferences, including a major San Francisco healthcare meeting, have stepped up security for attendees this ...

The four-day conference drew roughly 8,000 attendees and featured presentations from more than 500 private and public ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

As I ran from interview to interview across San Francisco, I was consistently warmed by the stories I was told by biotech and ...

San Francisco law enforcement and city leaders are gearing up for a big month ahead and are warning people to be on alert for ...

Radiopharmaceuticals company Telix Pharmaceuticals has provided its Q4 FY24 trading update, showing sustained revenue growth.

Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.